Search

Your search keyword '"Bassiri H"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Bassiri H" Remove constraint Author: "Bassiri H"
80 results on '"Bassiri H"'

Search Results

51. Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

52. Cutting Edge: Murine NK Cells Degranulate and Retain Cytotoxic Function without Store-Operated Calcium Entry.

53. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.

54. Antitumor Responses of Invariant Natural Killer T Cells.

55. iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .

56. Invariant NKT cells: Killers and conspirators against cancer.

57. The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation.

58. Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function.

59. Left main coronary artery dissection after valve replacement: role of coronary computed tomographic angiography.

60. It's up to you Egr2.

61. The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenic NKT cells via effects on GATA-3 and T-bet expression.

62. Differential requirement for the SAP-Fyn interaction during NK T cell development and function.

63. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

64. Evaluation of atrial thrombus formation and atrial appendage function in patients with pacemaker by transesophageal echocardiography.

65. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection.

66. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.

67. Thymic stromal-cell abnormalities and dysregulated T-cell development in IL-2-deficient mice.

68. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.

69. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.

70. Delayed allograft rejection by T cell receptor V beta 8.1 transgenic mice peripherally tolerized to Mls-1.

71. Prolonged survival of class I deficient mouse islet allografts but not xenografts.

72. Allograft rejection by T cell receptor transgenic mice.

73. Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells.

74. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.

75. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.

76. Donor antigen-specific T-lymphocyte deletion after intrathymic inoculation.

77. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts.

78. Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats.

80. Effect of lymphokine-induced MHC antigen expression on islet allograft survival.

Catalog

Books, media, physical & digital resources